Skip to main content
Caplight Logo









StimOxyGen

StimOxyGen

Private
ColeraineHealthcare & Life Scienceshttps://stimoxygen.com

Last Round

Seed

Mar 11, 2025

Total Funding Raised

$1.92M

Company Overview

StimOxyGen is a biotechnology company developing oxygen-generating nanoparticles to treat hypoxic solid tumours and enhance the efficacy of radiotherapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

nanoparticle therapeuticoxygen-generating nanoparticlestumor hypoxiaradiotherapy enhancementradiosensitizeroncology therapeuticsnanomedicinesolid tumor treatmentdrug developmentpH-sensitive drug deliverytumor microenvironmentpreclinical biotechpharmaceutical partnershipsuniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StimOxyGen Comparables

Compare StimOxyGen with similar companies based on industry and business-model similarity.

StimOxyGen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NuvOx Therapeutics
81%
Xerion Healthcare Limited
79%
KORTUC INC.
78%

StimOxyGen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 11, 2025

Key People

Founding team and executive leadership

Sian Farrell

Chief Executive Officer, Co-Founder

Founding Team

StimOxyGen Investors

Notable investors and investment history

StimOxyGen investors
InvestorRounds
Innovate UKSeed
QUBISSeed
Clarendon Fund ManagersSeed
DSW VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Monthly visitors grew 49% MoM.

StimOxyGen Filings

Explore SEC and related filing metadata, where available.

StimOxyGen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about StimOxyGen's valuation, stock price, and market status.

Is StimOxyGen a public or private company?

StimOxyGen is a private company.

What is the current stock price of StimOxyGen?

StimOxyGen is a private company with no public stock price. No recent secondary market data is available.

How much is StimOxyGen worth (valuation)?

Valuation information for StimOxyGen is not publicly available.

Can I buy StimOxyGen stock?

StimOxyGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was StimOxyGen's last funding round?

StimOxyGen's most recent funding round was Seed on March 11, 2025.

Who are the main investors in StimOxyGen?

Key investors in StimOxyGen include DSW Ventures.

Will StimOxyGen IPO soon?

No public IPO plans have been announced for StimOxyGen.

How can I track StimOxyGen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StimOxyGen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersColeraine
Employee Range5
Year Founded2021
Last FundingMar 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?